Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) was upgraded by investment analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report released on Wednesday, Zacks reports. A number of other brokerages also recently commented on PTGX. Wolfe Research reaffirmed an “outperform” rating on shares of Protagonist Therapeutics in a research […]

American Coastal Insurance (NASDAQ:ACIC – Get Free Report) was upgraded by stock analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Wednesday, Zacks reports. A number of other research analysts have also weighed in on ACIC. Raymond James Financial reaffirmed an “outperform” rating and set […]

ODDITY Tech (NASDAQ:ODD – Get Free Report) was upgraded by equities researchers at Zacks Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Wednesday, Zacks reports. Several other research analysts have also recently issued reports on ODD. JPMorgan Chase & Co. started coverage on ODDITY Tech in a […]

CECO Environmental (NASDAQ:CECO – Get Free Report) was upgraded by investment analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report issued on Tuesday, Zacks reports. Other equities research analysts have also recently issued research reports about the stock. Weiss Ratings cut shares of CECO Environmental from a “hold (c-)” […]

TWFG (NASDAQ:TWFG – Get Free Report) was upgraded by Zacks Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Monday, Zacks reports. A number of other analysts have also issued reports on the stock. Morgan Stanley upgraded shares of TWFG from an “equal weight” rating to an “overweight” […]

LivaNova (NASDAQ:LIVN – Get Free Report) was upgraded by investment analysts at Barclays to a “strong-buy” rating in a report issued on Wednesday, Zacks reports. A number of other equities analysts have also recently commented on the stock. Needham & Company LLC lifted their price objective on shares of LivaNova from $81.00 to $93.00 and […]